Ionis Pharmaceuticals, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $267.95Mn |
Net Profits | $-114.65Mn |
Net Profit Margins | -42.79% |
Ionis Pharmaceuticals, Inc. Common Stock’s revenue fell -40.73% since last year same period to $267.95Mn in the Q2 2026. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. Common Stock has generated 8.88% jump in its revenue since last 3-months.
Ionis Pharmaceuticals, Inc. Common Stock’s net profit fell -192.79% since last year same period to $-114.65Mn in the Q2 2026. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. Common Stock has generated -23.9% fall in its net profits since last 3-months.
Ionis Pharmaceuticals, Inc. Common Stock’s net profit margin fell -256.55% since last year same period to -42.79% in the Q2 2026. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. Common Stock has generated -13.8% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.09 |
EPS Estimate Current Year | -1.09 |
Ionis Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -1.09 - a -41.56% fall from last quarter’s estimates.
Ionis Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -1.09.
Key Ratios
Earning Per Share (EPS) | -0.7 |
Ionis Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) fell -182.35% since last year same period to -0.7 in the Q2 2026. This indicates that the Ionis Pharmaceuticals, Inc. Common Stock has generated -182.35% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-29 | -0.77 | -0.3 | 61.04% |
2026-07-29 | -1.09 | -0.7 | 35.78% |
